Abstract
Functional transgenesis in laboratory mice was first reported in the early 1980s, when investigators expressed human growth hormone, producing abnormal growth (1). Since that time, innumerable variations in transgene configuration have resulted in greater control over exogenous gene expression levels, timing, tissue/cell type distribution, and gene product localization. Significant progress toward adapting these systems for use in agricultural mammals began a few years after the technology's murine debut, with the production of transgenic rabbits, sheep, pigs (2), goats (3), and cattle (4) expressing exogenous proteins in their milk. Up to this point, investigators used pronuclear microinjection, the original method developed in mice, to create these transgenic animals. Briefly, fertilized embryos are collected from superovulated donors at the one-cell “zygote” stage before syngamy, the fusion of maternal and paternal pronuclei. Highly purified transgene DNA is injected into one of the two pronuclei, and the injected embryos are allowed to develop in culture. Embryos that survive the process are then transferred into a pseudopregnant recipient uterus for gestation, and live offspring are screened for the presence of the transgene. Although success rates for introducing transgenes in this way vary based on species and transgene DNA construct, they are typically low (usually 1–5% of injected embryos), and other DNA integration strategies, including the use of reverse-transcribed gene transfer … *To whom correspondence should be addressed. E-mail: xiangzhong.yang{at}uconn.edu

This publication has 12 references indexed in Scilit: